These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 31583693

  • 1. An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists.
    O'Sullivan SM, Farrant MT, Ogilvie CM, Gunn AJ, Milsom SR.
    Aust N Z J Obstet Gynaecol; 2020 Jun; 60(3):405-411. PubMed ID: 31583693
    [Abstract] [Full Text] [Related]

  • 2. Prolactinoma and pregnancy: From the wish of conception to lactation.
    Maiter D.
    Ann Endocrinol (Paris); 2016 Jun; 77(2):128-34. PubMed ID: 27130071
    [Abstract] [Full Text] [Related]

  • 3. Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center.
    Prencipe N, Bona C, Cuboni D, Berton AM, Bioletto F, Varaldo E, Aversa LS, Sibilla M, Gasco V, Ghigo E, Grottoli S.
    Pituitary; 2024 Jun; 27(3):269-276. PubMed ID: 38499816
    [Abstract] [Full Text] [Related]

  • 4. Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients.
    Domingue ME, Devuyst F, Alexopoulou O, Corvilain B, Maiter D.
    Clin Endocrinol (Oxf); 2014 May; 80(5):642-8. PubMed ID: 24256562
    [Abstract] [Full Text] [Related]

  • 5. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    Ono M, Miki N, Amano K, Kawamata T, Seki T, Makino R, Takano K, Izumi S, Okada Y, Hori T.
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of Patients with Macroprolactinoma Desiring Pregnancy: Follow-Up to 23 Years from a Single Center.
    Tanrikulu S, Yarman S.
    Horm Metab Res; 2021 Jun; 53(6):371-376. PubMed ID: 33902136
    [Abstract] [Full Text] [Related]

  • 7. Pregnancy and Tumor Outcomes in Women with Prolactinoma.
    Araujo B, Belo S, Carvalho D.
    Exp Clin Endocrinol Diabetes; 2017 Nov; 125(10):642-648. PubMed ID: 28704852
    [Abstract] [Full Text] [Related]

  • 8. [Management of prolactinomas during pregnancy].
    Chen W, Bian X, Gai M, Zhang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun 18; 37(6):335-7. PubMed ID: 12126566
    [Abstract] [Full Text] [Related]

  • 9. Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation.
    Auriemma RS, Perone Y, Di Sarno A, Grasso LF, Guerra E, Gasperi M, Pivonello R, Colao A.
    J Clin Endocrinol Metab; 2013 Jan 18; 98(1):372-9. PubMed ID: 23162092
    [Abstract] [Full Text] [Related]

  • 10. Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy.
    Rastogi A, Bhadada SK, Bhansali A.
    Gynecol Endocrinol; 2017 Apr 18; 33(4):270-273. PubMed ID: 27908214
    [Abstract] [Full Text] [Related]

  • 11. Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal.
    Santharam S, Fountas A, Tampourlou M, Arlt W, Ayuk J, Gittoes N, Toogood A, Karavitaki N.
    Clin Endocrinol (Oxf); 2018 Sep 18; 89(3):346-353. PubMed ID: 29894000
    [Abstract] [Full Text] [Related]

  • 12. Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women.
    Lebbe M, Hubinont C, Bernard P, Maiter D.
    Clin Endocrinol (Oxf); 2010 Aug 18; 73(2):236-42. PubMed ID: 20455894
    [Abstract] [Full Text] [Related]

  • 13. A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas.
    Sant' Anna BG, Musolino NRC, Gadelha MR, Marques C, Castro M, Elias PCL, Vilar L, Lyra R, Martins MRA, Quidute ARP, Abucham J, Nazato D, Garmes HM, Fontana MLC, Boguszewski CL, Bueno CB, Czepielewski MA, Portes ES, Nunes-Nogueira VS, Ribeiro-Oliveira A, Francisco RPV, Bronstein MD, Glezer A.
    Pituitary; 2020 Apr 18; 23(2):120-128. PubMed ID: 31728906
    [Abstract] [Full Text] [Related]

  • 14. Management of prolactinomas during pregnancy.
    Molitch ME.
    J Reprod Med; 1999 Dec 18; 44(12 Suppl):1121-6. PubMed ID: 10649822
    [Abstract] [Full Text] [Related]

  • 15. Prolactin, prolactin disorders, and dopamine agonists during pregnancy.
    Levin G, Rottenstreich A.
    Hormones (Athens); 2019 Jun 18; 18(2):137-139. PubMed ID: 30341577
    [Abstract] [Full Text] [Related]

  • 16. Pituitary apoplexy of a giant prolactinoma during pregnancy.
    Khaldi S, Saad G, Elfekih H, Ben Abdelkrim A, Ach T, Kacem M, Chaieb M, Maaroufi A, Hasni Y, Ach K.
    Gynecol Endocrinol; 2021 Sep 18; 37(9):863-866. PubMed ID: 34124989
    [Abstract] [Full Text] [Related]

  • 17. Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
    Lambert K, Rees K, Seed PT, Dhanjal MK, Knight M, McCance DR, Williamson C.
    Obstet Gynecol; 2017 Jan 18; 129(1):185-194. PubMed ID: 27926659
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E, Camanni F.
    Drugs; 1996 Jun 18; 51(6):954-65. PubMed ID: 8736617
    [Abstract] [Full Text] [Related]

  • 19. Prolactinoma Outcome After Pregnancy and Lactation: A Cohort Study.
    Laway BA, Baba MS, Bansiwal SK, Choh NA.
    Indian J Endocrinol Metab; 2021 Jun 18; 25(6):559-562. PubMed ID: 35355922
    [Abstract] [Full Text] [Related]

  • 20. [Fertility in prolactinomas--considerations concerning some clinical cases].
    Ionescu O, Vulpoi C, Ungureanu MC, Ionescu D, Zbranca E.
    Rev Med Chir Soc Med Nat Iasi; 2001 Jun 18; 105(4):806-9. PubMed ID: 12092244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.